NeuroGT is developing gene therapy products to treat rare neurogenetic diseases.
Company Details
Company type
Year founded
2019
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)
Products under development
AAV gene therapy for MPS I, MPS II, MPS IIIA, MPS IIIB, MPS IIIC